Advancing pharmacy and healthcare with virtual digital technologies.

Journal: Advanced drug delivery reviews
PMID:

Abstract

Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally. From the different technologies, virtual tools including artificial intelligence, blockchain, virtual, and augmented reality, to name but a few, are providing significant benefits to patients and the pharmaceutical sector alike, ranging from improving access to clinicians and medicines, as well as improving real-time diagnoses and treatments. Indeed, it is envisioned that such technologies will communicate together in real-time, as well as with their physical counterparts, to create a large-scale, cyber healthcare system. Despite the significant benefits that virtual-based digital health technologies can bring to patient care, a number of challenges still remain, ranging from data security to acceptance within the healthcare sector. This review provides a timely account of the benefits and challenges of virtual health interventions, as well an outlook on how such technologies can be transitioned from research-focused towards real-world healthcare and pharmaceutical applications to transform treatment pathways for patients worldwide.

Authors

  • Sarah J Trenfield
    UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
  • Atheer Awad
    UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
  • Laura E McCoubrey
    UCL School of Pharmacy, University College London , London, UK.
  • Moe Elbadawi
    UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; School of Biological and Behavioural Sciences, Queen Mary University of London, Mile End Road, London E1 4DQ, UK. Electronic address: m.elbadawi@qmul.ac.uk.
  • Alvaro Goyanes
    Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, 15782, Spain. Electronic address: a.goyanes@FabRx.co.uk.
  • Simon Gaisford
    UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: s.gaisford@ucl.ac.uk.
  • Abdul W Basit
    Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK. Electronic address: a.basit@ucl.ac.uk.